X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (545) 545
Publication (73) 73
Book Review (8) 8
Patent (5) 5
Conference Proceeding (4) 4
Dissertation (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (257) 257
index medicus (181) 181
male (167) 167
female (140) 140
middle aged (117) 117
atherosclerosis (113) 113
adult (95) 95
cardiac & cardiovascular systems (91) 91
cholesterol (81) 81
risk factors (70) 70
animals (69) 69
aged (64) 64
inflammation (60) 60
peripheral vascular disease (60) 60
lipids (56) 56
cardiovascular disease (53) 53
cardiovascular (52) 52
lipoproteins (41) 41
internal medicine (36) 36
endocrinology & metabolism (34) 34
cardiovascular-disease (33) 33
risk (33) 33
statins (33) 33
c-reactive protein (31) 31
high-density-lipoprotein (31) 31
medicine, general & internal (31) 31
article (30) 30
abridged index medicus (29) 29
hematology (29) 29
therapy (29) 29
biochemistry & molecular biology (28) 28
diabetes (28) 28
cholesterol, ldl - blood (27) 27
double-blind method (27) 27
in-vivo (27) 27
mice (27) 27
triglycerides (27) 27
care and treatment (26) 26
endothelium (26) 26
coronary-heart-disease (25) 25
density-lipoprotein cholesterol (25) 25
genetic aspects (25) 25
myocardial-infarction (25) 25
research (25) 25
treatment outcome (25) 25
coronary-artery-disease (24) 24
familial hypercholesterolemia (24) 24
hypercholesterolemia (24) 24
prospective studies (24) 24
case-control studies (23) 23
cholesterol, hdl - blood (22) 22
medical colleges (22) 22
mutation (22) 22
disease (21) 21
time factors (21) 21
physiological aspects (20) 20
apolipoproteins (19) 19
biomarkers - blood (19) 19
clinical trials (19) 19
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (19) 19
nitric oxide (19) 19
pharmacology & pharmacy (19) 19
research article (19) 19
analysis (18) 18
anticholesteremic agents - therapeutic use (18) 18
cardiovascular diseases (18) 18
hdl (18) 18
health aspects (18) 18
mortality (18) 18
risk assessment (18) 18
triglycerides - blood (18) 18
type 2 diabetes (18) 18
blood pressure (17) 17
cholesterol - blood (17) 17
heart-disease (17) 17
hypolipidemic agents - therapeutic use (17) 17
intima-media thickness (17) 17
lipids - blood (17) 17
low density lipoproteins (17) 17
metabolic syndrome (17) 17
multidisciplinary sciences (17) 17
adolescent (16) 16
drug therapy (16) 16
endothelium, vascular - physiopathology (16) 16
expression (16) 16
insulin-resistance (16) 16
low-density-lipoprotein (16) 16
prevalence (16) 16
prevention (16) 16
randomized controlled-trial (16) 16
studies (16) 16
atherosclerosis - drug therapy (15) 15
cardiology and cardiovascular medicine (15) 15
cardiovascular diseases - prevention & control (15) 15
immunology (15) 15
medicine (15) 15
risk-factors (15) 15
safety (15) 15
science (15) 15
atherosclerosis - pathology (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 12, p. e14262
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Cell Metabolism, ISSN 1550-4131, 10/2017, Volume 26, Issue 4, pp. 611 - 619.e6
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2014, Volume 111, Issue 3, pp. 1078 - 1083
Journal Article